drugset / Trial / NCT00885937

Comparative Safety Study of New Sinecort Formulation Versus Positive Control

NCT00885937

Phase 1 Completed 33 enrolled Bayer
RandomizedSingle-groupSingle-blindTreatment

Summary

The study is focused to prove a favorable safety profile of the new formulation.

Timeline

Start
2009-04
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexpanthenol Small molecule 0.05 ml
Comparator Na-laurylsulfat Unknown 0.5 % Topical

Indications

No indication recorded.